Dr. Eyal Raz, Professor of Medicine in the University of California San Diego, received his MD degree in 1981 from the Hebrew University at the Hadassah Medical School, Jerusalem, Israel.
The research in his laboratory explores questions in basic science and attempts to apply its results to translational research/medicine. Over the last decade, the Raz laboratory has explored diverse biological aspects induced by various microbial PAMPs on the activation of innate immunity, adaptive immunity and their impact on vaccination and the regulation of inflammatory responses such as allergic diseases. These findings led to the founding of a few biotech companies, one of them Dynavax, of which he was a Director and the Chief Scientific Officer during 1997-2000, is in the final stage of clinical trials. Current projects in his laboratory are addressing the role of TRP channels on T cell and epithelial cell activation.